NDAORALCAPSULE
Approved
Oct 2008
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
2
Mechanism of Action
Adrenergic alpha-Antagonists
Pharmacologic Class:
alpha-Adrenergic Blocker
Clinical Trials (2)
Effectiveness and Safety of Silodosin in the Treatment of Benign Prostatic Hyperplasia
Started May 2011
1,036 enrolled
Benign Prostatic Hyperplasia
Evaluation of the Efficacy and Safety of Silodosin in the Treatment of the Signs and Symptoms of BPH
Started May 2006
1,228 enrolled
Benign Prostatic Hyperplasia